MYDA Advisors LLC bought a new position in Walgreens Boots Alliance Inc (NASDAQ:WBA) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 5,000 shares of the pharmacy operator’s stock, valued at approximately $363,000.
Other institutional investors have also recently modified their holdings of the company. Westside Investment Management Inc. lifted its stake in Walgreens Boots Alliance by 10.4% in the 2nd quarter. Westside Investment Management Inc. now owns 1,325 shares of the pharmacy operator’s stock worth $102,000 after purchasing an additional 125 shares in the last quarter. Zions Bancorporation lifted its stake in Walgreens Boots Alliance by 983.3% in the 3rd quarter. Zions Bancorporation now owns 1,365 shares of the pharmacy operator’s stock worth $105,000 after purchasing an additional 1,239 shares in the last quarter. IHT Wealth Management LLC lifted its stake in Walgreens Boots Alliance by 46.3% in the 2nd quarter. IHT Wealth Management LLC now owns 6,946 shares of the pharmacy operator’s stock worth $135,000 after purchasing an additional 2,199 shares in the last quarter. Bristlecone Advisors LLC purchased a new stake in Walgreens Boots Alliance in the 3rd quarter worth $135,000. Finally, Trustcore Financial Services LLC purchased a new stake in Walgreens Boots Alliance in the 4th quarter worth $155,000. 61.00% of the stock is owned by institutional investors.
Walgreens Boots Alliance Inc (NASDAQ WBA) traded down $1.31 on Wednesday, reaching $68.55. 5,800,000 shares of the company were exchanged, compared to its average volume of 5,670,000. The company has a quick ratio of 0.47, a current ratio of 0.96 and a debt-to-equity ratio of 0.48. Walgreens Boots Alliance Inc has a 52-week low of $63.82 and a 52-week high of $87.79. The firm has a market capitalization of $67,910.00, a price-to-earnings ratio of 18.94, a PEG ratio of 1.16 and a beta of 1.21.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 EPS for the quarter, topping analysts’ consensus estimates of $1.27 by $0.01. Walgreens Boots Alliance had a net margin of 3.19% and a return on equity of 19.15%. The company had revenue of $30.74 billion for the quarter, compared to the consensus estimate of $30.39 billion. During the same period in the previous year, the firm earned $1.10 earnings per share. Walgreens Boots Alliance’s quarterly revenue was up 7.9% compared to the same quarter last year. equities analysts anticipate that Walgreens Boots Alliance Inc will post 5.79 EPS for the current year.
The company also recently announced a quarterly dividend, which was paid on Monday, March 12th. Shareholders of record on Thursday, February 15th were paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 2.33%. The ex-dividend date of this dividend was Wednesday, February 14th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 44.20%.
In other news, insider Stefano Pessina bought 98,858 shares of Walgreens Boots Alliance stock in a transaction on Monday, January 15th. The shares were bought at an average cost of $76.07 per share, with a total value of $7,520,128.06. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 14.80% of the stock is owned by insiders.
Several analysts have commented on the stock. Zacks Investment Research cut shares of Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a research note on Monday, January 22nd. Mizuho set a $87.00 price target on shares of Walgreens Boots Alliance and gave the stock a “buy” rating in a research note on Wednesday, January 24th. ValuEngine cut shares of Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a research note on Friday, February 2nd. Evercore ISI assumed coverage on shares of Walgreens Boots Alliance in a research note on Thursday, January 4th. They issued an “outperform” rating and a $80.00 price target on the stock. Finally, Loop Capital set a $90.00 price target on shares of Walgreens Boots Alliance and gave the stock a “buy” rating in a research note on Wednesday, January 3rd. One research analyst has rated the stock with a sell rating, eleven have issued a hold rating, eleven have assigned a buy rating and one has issued a strong buy rating to the company. The company presently has an average rating of “Buy” and an average price target of $84.75.
TRADEMARK VIOLATION NOTICE: This news story was posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are viewing this news story on another site, it was copied illegally and reposted in violation of United States & international copyright & trademark legislation. The original version of this news story can be viewed at https://ledgergazette.com/2018/03/15/5000-shares-in-walgreens-boots-alliance-inc-wba-acquired-by-myda-advisors-llc.html.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.